News
Capital Market on MSN1h
Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilarsDenosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback